The human granulocyte colony-stimulating factor (G-CSF) is routinely applied in various cancer chemotherapy regimen in order to ameliorate or prevent neutropenia caused by the unspecific toxicity of the drugs used[1-4]. The gene discussed is CSF3; the disease is Decreased total neutrophil count.